Karyopharm Therapeutics Inc. 4
4 · Karyopharm Therapeutics Inc. · Filed Jul 9, 2014
Insider Transaction Report
Form 4
WEG KENNETH E
Director
Transactions
- Award
Nonstatutory Stock Option (right to buy)
2014-07-08+10,000→ 10,000 totalExercise: $36.04Exp: 2024-07-07→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]This option vests as to 100% of the underlying shares on June 9, 2015, provided that the holder continues to serve as a director of the issuer through such date.